Trypanosomes carried by the tsetse fly are responsible for African sleeping sickness, a serious health risk in Sub-Saharan Africa which is spreading in travelers to Europe and the United States (1) (2) (3) . Sterol biosynthesis is an extremely important area of biochemical difference between these protozoan parasites and their animal hosts that might be exploited in the development of new chemotherapeutic leads. Therefore, it is notable that Trypanosoma brucei operates a phyla-specific ergosterol biosynthesis pathway distinct from other Kinetoplastids or fungi, and produce a sterol metabolome that is different from animals ( Figure 1 ) (4) (5) (6) .
. The uniqueness of ergosterol biosynthesis and homeostasis in T. brucei resides primarily in formation of a 24β-methyl group in the sterol side chain structure catalyzed by sterol C24-methyl transferase (TbSMT) and in the amount of final product -ergosterol, utilized in growth support. Detailed studies of metabolism using 13 C-and 2 H-labeled intermediates supported by mechanistic analysis of the cloned TbSMT reveal the introduction of the C24β-methyl group in the sterol side chain proceeds in T. brucei by a methylation-deprotonation ∆ 25(27) -olefin pathway which likely diverged from the methylation-deprotonation ∆ 24(28) -olefin pathway yielding fungal ergosterol very early in the evolution of eukaryotes (6) (7) (8) .
T. brucei encounters diverse environments during its life cycle with the different stages taking on very different sterol compositions. Despite having an intact ergosterol biosynthesis pathway in the procyclic forms (PCFs), the blood stream forms (BSFs) are generally considered to lack ergosterol biosynthesis and to be auxotrophic for sterol (9) (10) (11) (12) (13) . At this stage, cells satisfy their sterol requirements through dietary supplementation of cholesterol via lipoproteins in full growth medium present in the blood meal (10, 11) .
Consequently, the existence of a sterol uptake process which permits the formation of BSF membranes containing exclusively cholesterol could provide resistance to a range of antifungal drugs, e.g. amphotericin B, that function typically in membranes formed by ergosterol (14, 15) . However, all the genes for ergosterol biosynthesis have been found recently to be expressed in BSF (16, 17) and inhibitors of the post-squalene portion of ergosterol biosynthesis can inhibit growth of BSF (4, (18) (19) (20) ; therefore, the ability for BSF to grow as an ergosterol-depleted protozoan with dietary cholesterol as an ergosterol surrogate remains enigmatic.
In nature, sterols are chiefly used as structural components of membranes (21, 22) .
Mammalian cell membranes are considered to be more flexible than fungal or protozoan cell membranes (23) , and the chemodiversity in sterol biosynthesis may contribute to their architectural suitability (24) . However, there is growing evidence the sterol requirements for membrane structures across kingdoms are rather broad and can be met by several closely related compounds. Thus cholesterol can be shown to replace ergosterol in yeast membranes and phytosterols can be shown to replace cholesterol in animal membranes (25) (26) (27) (28) . On the other hand, functional diversity of sterols is reported to exist, with emphasis on the variation in sterol side chain structures which contribute to the regulatory role that sterols per se may play apart from modulating the bulk physical properties of the membrane. For yeast, the "regulatory role" of ergosterol -also referred to as sparking (29) -is to provide direct integration of a chemical switch into membrane domains to signal cell proliferation and possibly affect cell shape (29) (30) (31) . The phenomenon by which ergosterol can play dual roles in yeast has been defined as sterol synergism (26) and the two kinds of function-bulk and sparking-can be distinguished quantitatively from each other by differing sensitivities to the 24β-methyl group of the sterol's structure (31) .
Given the possibility that BSF generate ergosterol in small amounts to promote growth and accessibility of very few therapeutic drugs with many produced over 30 years ago, and toxicity issues (32, 33) , we examined the concentration dependence of ergosterol in T. brucei growth and evaluated the potential use of targeted enzymes of ergosterol biosynthesis for future therapies. Here we demonstrate that quantitative differences in the ergosterol content of PCF or BSF of different infective types contribute to variations in the growth response. Additionally, by examination of the knock down of
TbSMT and TbSDM (sterol 14α-demethylase) gene expression together with inhibitor treatment of PCF and BSF cultured in vitro or in vivo using infected mice we show that C24-sterol methylation and ergosterol are the sine qua non of sparking trypanosome proliferation.
the same medium containing appropriate antibiotics (hygromycin; 50µg/ml; G418; 15µg/ml) (36, 37) . Bloodstream form cells were maintained in HMI-9 media supplemented with 10% heat-inactivated FBS (Atlanta Biologicals) and 10% serum plus (SAFC Biosciences), which is a full-growth medium. T. brucei 427 SM cell line, resistant to G418, expressing the tetracycline repressor gene (TetR) and T7RNA polymerase (T7RNP), was grown in the same medium containing G418 (2.5 µg/ml). For preparation of low-cholesterol medium (LDM), procyclic forms in SDM-79 medium was supplemented with 10% heat-inactivated lipid-free FBS (Sigma-Aldrich). For a lowcholesterol medium, the bloodstream form cells were grown in HMI-9 medium containing 10% lipid-free heat-inactivated FBS (Sigma-Aldrich). For growth curves, 24-SMT and 14-SDM RNAi engineered cells were diluted into FGM or LDM, induced by
RNAi by the addition of DOX (1 µg/ mL final) and cell density monitored for another 4-6 days. Typically, procyclic cells were inoculated at 2-3 x 10 6 cells/mL and bloodstream form cells inoculated at 1 x 10 5 cells/mL in media containing antibiotic and cultured for 6-8 days. Cell densities were maintained in the range of 0.5-1 X 10 7 cells/ml for the procyclic form and 0.1-1 x 10 6 cells/ml for the bloodstream form by reinoculation in fresh medium. Cells were harvested by centrifugation. TbSMT inhibitors and itraconazole were added to procyclic form or bloodstream form cells from stock solutions in dimethyl sulphoxide such that the organic solvent was less than 1% (v/v) of total culture volume.
Five different concentrations of each compound were tested in triplicate between 0 (control) and 10 µM; the 50% growth inhibition reported as the IC 50 relative to the growth of control. Cell densities were determined using a Neubauer hemocytometer counter. The cumulative cell number was plotted versus time of growth.
Human epithelial cells (HEK 293T) were purchased from ATCC (Manassas, VA).
HEK cells were cultured at 37 0 C in humidified 5% CO2 incubator in Dulbecco's modified eagle medium (DMEM, Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum. Cell viability was checked by trypan blue dye exclusion as described (38, 39) . A set of subspecies of T. brucei trypomastigotes -T. brucei brucei (strains 328-114 and 427), T. brucei rhodesiense (Etatl.2S) and T. brucei gambiense (LiTatl.3) were cultured as described above (40) .
Northern Blot analysis
Total RNA was isolated from T. brucei procyclic and bloodstream forms 24-SMT RNAi and 14-SDM RNAi cell lines grown in the presence and absence of doxycycline using
Trizol reagent (Invitrogen) and Northern blot analysis was performed as described (41) .
Total RNA (5-10 µg) was loaded per lane and the blot was probed with 32 P labeled DNA probe corresponding to the same SMT sequence corresponding to the SMT RNAi.
Inhibition of TbSMT activity
Initially, the steady-state kinetic parameters, K m , and V max, were established using lysate of E. coli (8 
Sterol isolation and analysis
T. brucei cell pellets were saponified directly in 10% KOH in 80% aqueous methanol at the reflux temperature for one hr, which yielded total sterol (free plus esterified sterols). 
Generation of T. brucei RNAi cell lines
To prepare the construct for TbSMT double stranded RNA expression the 588 bp fragment of the coding region was PCR amplified from T. brucei genomic DNA by using high-fidelity pfu polymerase (Stratagen). Sense and antisense primers containing the restriction sites for BamH1 and HindIII at the 5' ends were TbSMTFor:
5'agtcggatcctgtgaatggcgatgtgaatgc3' and TbSMTRev:
5'agtcaagcttcatacaggtccgtcaaacaccac3', respectively. The amplified product was cloned into the BamH1/HindIII sites of a tetracycline inducible dual-promoter olasmid vector, 
Treatment of 24SMT inhibitors on T. brucei bloodstream form in vivo
There were 3 groups of mice and each group had 6 mice. 
RESULTS

Ergosterol is synthesized variably in wild-type PCF and BSF
Growth of wild-type PCF strain 427 in full growth medium, which provides 678 µM (262 µg/ml) cholesterol (4), followed a logarithmic course with a doubling time of 12 hrs and yielded cell densities at 6 days of 1-3 x 10 7 per ml. When these cells were extracted, the GC-MS analysis of the neutral lipid fraction showed the presence of cholesterol and a set of endogenously formed 24-desalkyl (mostly cholesta-5,7,24-trienol) and 24-alkyl sterols (mostly ergosta-5,7,25(27)-trienol) in approximate 50:50 ratio (Table 1) . Ergosterol in GC at RRT c 1.11 was determined to be in trace amounts. Table 1 ). The accumulation of endogenously formed 14α-methyl sterols which might be considered as toxic intermediates was not particularly pronounced in the DOX-induced RNAi lines.
DOX-induced
TbSMT and TbSDM RNAi lines produce minor amounts of endogenously formed sterol while cholesterol from the media is the major cellular sterol (Table 1) foregoing results imply that the reason why PCF are responsive to ergosterol biosynthesis inhibitors is that small amounts of ergosterol are required for essential cell functions rather than that they accumulate unusual sterols which may perturb membrane structures.
Kinetic analysis
Kinetic studies were carried out to investigate the interaction of TbSMT and the test drugs. Previously, the TbSMT was cloned and the optimal substrate for activity shown as zymosterol (K m = 47 µM, k cat = 0.6 min 
Effects of inhibitors and RNAi treatment of TbSMT on BSF growth and in vivo infections
All the test drugs demonstrated clear dose-dependent inhibitory effect on BSF cells cultured in FGM (Supplementary Figures 8 and 11 ) with ED 50 values that ranged from 1-3 µM, while they failed to inhibit cultured human epithelial cells (HEK) at greater than or equal to 50 µM (Table 1) 
Small amounts of ergosterol are essential for cell proliferation
To determine whether the absence of ergosterol production is responsible for the growth phenotype observed using ergosterol biosynthesis inhibitors, we developed 
